The Effect of Ibuprofen Dosing Interval on Post-Tonsillectomy Outcomes in Children: A Quality Improvement Study

Grayson Mast1, Krysta Henderson2, Michele M Carr3

  • 1School of Medicine, West Virginia University, Morgantown, WV, USA.

Insights

Increasing the dosing interval for alternating Acetaminophen and Ibuprofen in pediatric tonsillectomy patients reduced post-tonsillectomy hemorrhage (PTH) and emergency room visits without compromising pain management.

Area of Science:

  • Pediatric Otolaryngology
  • Pain Management
  • Quality Improvement

Background:

  • Post-tonsillectomy hemorrhage (PTH) is a significant concern in pediatric care.
  • Optimizing postoperative analgesia is crucial for patient recovery and reducing healthcare utilization.
  • Current pain management protocols often involve alternating Acetaminophen and Ibuprofen.

Purpose of the Study:

  • To evaluate the impact of increased dosing intervals for alternating Acetaminophen and Ibuprofen on PTH rates.
  • To assess the effect on emergency room (ER) visits for non-hemorrhage reasons.
  • To determine if analgesia standards were maintained and caregiver calls were managed.

Main Methods:

  • A quality improvement project involving 353 pediatric patients undergoing tonsillectomy.
  • Initial phase: Acetaminophen 15 mg/kg q6h and Ibuprofen 10 mg/kg q6h.
  • Intervention phase: Lengthened dosing interval to q4h, data collected on PTH, ER visits, and phone calls.

Main Results:

  • Run chart analysis indicated lower PTH rates with the 4-hour dosing interval.
  • Patients on the 4-hour interval experienced fewer ER visits for reasons other than bleeding.
  • No increase in postoperative phone calls from caregivers regarding pain was observed.

Conclusions:

  • Lengthening the dosing interval for alternating Acetaminophen and Ibuprofen shows promise in reducing PTH and ER visits.
  • This modified analgesia protocol appears effective in pediatric tonsillectomy patients.
  • Further validation through a randomized clinical trial is recommended.
Abstract

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
336
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
123
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
9.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
168
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
164
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
1.3K